Janos Botyanszki

Title: Janos Botyanszki: Innovator in DNA Polymerase Theta Inhibition

Introduction

Janos Botyanszki is a notable inventor based in Norristown, PA (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that target DNA polymerase theta.

Latest Patents

His most recent patent, titled "Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof," focuses on compounds that inhibit DNA Polymerase Theta (Polθ) activity. These compounds are particularly effective in inhibiting the ATP-dependent helicase domain activity of Polθ. The patent also discusses pharmaceutical compositions that include these compounds and their potential applications in treating diseases such as cancer, especially homologous recombination (HR) deficient cancers.

Career Highlights

Janos has worked with prominent companies in the pharmaceutical and biotechnology sectors. He has been associated with Ideaya Biosciences, Inc. and GlaxoSmithKline Intellectual Property (No.2) Limited. His work in these organizations has contributed to advancements in cancer treatment and drug development.

Collaborations

Throughout his career, Janos has collaborated with talented professionals, including Kevin Duffy and Young Eun Choi. These collaborations have further enhanced his research and development efforts in the field.

Conclusion

Janos Botyanszki is a distinguished inventor whose work on DNA polymerase theta inhibitors has the potential to impact cancer treatment significantly. His contributions to the field are noteworthy and reflect his dedication to advancing medical science.